overdosing on semaglutide ABC FDA Warns Against Using Compounded

P.Dos SantosC

The FLOW trial (Perkovic et al., New England Journal of Medicine , 2024) specifically studied semaglutide in CKD patients and found no need for dose adjustment

Note: Responses have been edited for length/clarity.

Moreover, glutathione helps manage oxidative stress caused by pollution, UV exposure, and lifestyle factors, thereby slowing visible skin aging

Importantly, no signals of drug-induced liver injury have emerged despite extensive real-world use, supporting the favorable hepatic safety profile of GLP-1 RAs [62]

However, given the small sample sizes of these RCTs, the generalizability of the findings is limited